跳至主要内容
临床试验/ACTRN12616001714471
ACTRN12616001714471已完成未知

Effects of 12-week dairy-derived nutritional supplementation combined with physical activity on health and physical function on healthy middle aged women after a 2-week period of reduced activity

Anthony Blazevich0 个研究点目标入组 100 人开始时间: 2016年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 60 Years(—)
性别
Female

入选标准

  • 1.age = 40-60 y
  • 3.BMI (18 -35 kg/m2)
  • 4.Sedentary to moderately active

排除标准

  • 1.Previous negative reaction to milk or dairy proteins
  • 2.Previous negative reaction to fish
  • 3.Currently perform structured physical activity in their occupation
  • 4.Baseline protein above 1.2 g/kg/day
  • 5.Calcium intake of > 750 mg/day
  • 6.Alcohol > 14 drinks per week (average)
  • 7.Smoking (or only having stopped smoking within the last 2 years)
  • 8.T-score bone mineral density (BMD) at either the hip or lumbar spine < -2.5
  • 9.Have any fixations (i.e. spine or femoral rods, hip replacements)
  • 10.Irregular menstrual cycle (not within 20-35 days); lack of cycle is not a criterion
  • 11.Using hormone replacement therapy
  • 12.Planning to become pregnant or currently breastfeeding
  • 13.Using supplements such as vitamin D (>400 IU), calcium, bone/joint assistants (glucosamine, chondroitin), or antacids containing calcium carbonate, and not willing to stop for at least 6 weeks prior to, and throughout, the duration of the trial.
  • 14.Anti-inflammatory use (including aspirin, ibuprofen, omega 3)
  • 15. Rheumatoid arthritis
  • 16.Use of beta blockers or ACE inhibitors
  • 17.Metabolic bone disease (including osteoporosis, osteomalacia, osteogenesis imperfect and Paget’s disease)
  • 18.Endocrine disorders (including hyper- or hypo-thyroidism, parathyroid disease, diabetes mellitus and Cushing’s syndrome)
  • 19.Cancer (including cervical, ovarian, uterine, breast, liver and of the gastrointestinal system)
  • 20.Other medical conditions impacting on digestion, including diseases of the gastrointestinal tract, or previous operations such as gastrectomy or intestinal resection, or the liver (i.e. cirrhosis).
  • 21.Any chronic muscle disease, disorder or injury
  • 22.Asthma that is not controlled or other respiratory diseases
  • 23.Self-reported personal or family history of deep vein thrombosis or similar clotting disorders

研究者

发起方
Anthony Blazevich

相似试验